Clinical development of anticancer agents incorporating micelles in oncological treatment

DOI Web Site 9 References
  • Matsumura Yasuhiro
    Division of Developmental Therapeutics, Center of Innovative Oncology, National Cancer Center Hospital East

Bibliographic Information

Other Title
  • がん治療におけるミセル製剤の臨床開発
  • ガン チリョウ ニ オケル ミセル セイザイ ノ リンショウ カイハツ

Search this article

Description

Anticancer agents categorized in DDS based on nanotechnology have been approved. Regarding a pipeline of clinical development of micelle carrier system, several clinical trials are now underway not only in Japan but also in other countries. Among them, especially in this chapter, clinical status of NK105, paclitaxel incorporating micelle, NC-6004, cisplatin incorporating micelle, and NC-6300, epirubicin incorporating micelle will be described.

Journal

  • Drug Delivery System

    Drug Delivery System 28 (3), 215-220, 2013

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top